Clinical Trial: Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lung Cancer
Study Type: INTERVENTIONAL
Official Title: Phase II Study of Dose Attenuated Chemotherapy in Patients With Lung Cancer and Age > 70 and/or Comorbidities
Brief Summary:
This is an open-label, non-randomized, single-center, phase II study to evaluate the efficacy, toxicity and, tolerability of pre-specified dose attenuated chemotherapy regimens in lung cancer patients with comorbidities.
Read more